Academy of Managed Care Pharmacy (AMCP) has been recognized as a Power of Associations Silver Award by the American Society of Association Executives (ASAE) for its successful Health Disparities in Medication Use and Access Awareness initiative.
AMCP Partnership Forum Addresses Gaps in Adoption of Precision Medicine
AMCP Partnership Forum Addresses Gaps in Adoption of Precision Medicine
Alexandria, Va., June 26, 2025 — AMCP convened a diverse group of stakeholders for its Precision Medicine Partnership Forum to examine solutions that improve access, consistency, and quality in precision oncology. Attendees included patients, payers, pharmacy benefit managers, providers, pathologists, laboratory benefit managers, and leaders from advocacy organizations, coalitions, and professional associations. The multi-session event focused on aligning clinical guidelines, diagnostics, and managed care processes to ensure that innovation in cancer care leads to meaningful, equitable outcomes for patients.
Forum participants explored persistent challenges across the precision medicine access ecosystem, particularly in oncology. Experts pointed to fragmentation and misalignment as key contributors to care gaps, using the example of non-small cell lung cancer (NSCLC), and emphasized the need for system-level changes that better inform clinical decision making, reduce time to initiation with targeted therapies, and support guideline-concordant care.
Attendees recommended deeper collaboration between clinical organizations and managed care to support the uptake of biomarker testing, standardize a vernacular for stakeholders, and develop national quality standards to ensure clinical utility and enhance patient outcomes.
“We need to accelerate how we align care with clinical evidence, advance pathologist-initiated biomarker testing at diagnosis, and elevate precision medicine to improve patient outcomes,” said AMCP CEO Susan Cantrell, RPh, CAE. “The more precise the treatment, the better the likelihood that a patient reaches a successful outcome. Getting the right people together for these critical conversations is essential to AMCP’s mission to ensure patients get the therapies they need at a cost they can afford.”
AMCP will carry the momentum forward by integrating precision medicine across its research, advocacy, education, and convening platforms, including Nexus 2025, AMCP 2026, and virtual training opportunities. Additional efforts include collaborating with key partners, including the National Comprehensive Cancer Network (NCCN), the Association of Cancer Care Centers (ACCC), the Association for Molecular Pathology (AMP), and the American Society for Clinical Pathology (ASCP), to continue to address precision medicine care gaps.
AMCP would like to thank Valuate Health Consultancy for assisting with the development and moderation of the Forum. Thank you to our generous sponsors: AbbVie, AstraZeneca, Genentech, Illumina, Johnson & Johnson, KlearTrust, Lilly, Merck, Pfizer, and Sanofi. Their support for this vital topic paves the way for more equitable and accessible treatment plans in oncology and beyond.
To learn more about AMCP’s precision medicine initiatives, visit our Precision Medicine Landing Page.
About AMCP
AMCP is the professional association leading the way to help patients get the medications they need at a cost they can afford. AMCP’s diverse membership of pharmacists, physicians, nurses, biopharmaceutical professionals, and other stakeholders leverage their specialized expertise in clinical evidence and economics to optimize medication benefit design and population health management and help patients access cost-effective and safe medications and other drug therapies. AMCP members improve the lives of nearly 300 million Americans served by private and public health plans, pharmacy benefit management firms, and emerging care models.
Related
Removal of all members of ACIP at the Centers for Disease Control & Prevention (CDC) is nothing short of alarming. Vaccines are a vital component of American public health infrastructure, and their safety and efficacy is well-established by reliable clinical evidence. Pharmacists, including AMCP members, provide patients with vaccines that prevent serious illness, hospitalizations, and even death. In many states, pharmacists’ ability to administer these life-saving vaccines are tied to ACIP recommendations.
PDTs are evidence-based treatments that use software or virtual tools, and sometimes hardware, to deliver a clinical benefit to patients. They have many known uses, helping Americans identify, treat, and manage illnesses across a wide range of conditions, including post-traumatic stress disorder (PTSD), diabetes management, substance and opioid use disorder, attention-deficit hyperactivity disorder (ADHD), chronic back pain, decreasing eyesight, and more. PDTs are subject to review and authorization by the Food & Drug Administration (FDA) and must be prescribed by a health care provider.
Featured News & Resources
See Full Calendar
Other Events
AMCP Great Plains Day of Education
Other Events
AMCP Florida Day of Education 2025
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
